GSK plc (LSE: GSK, NYSE: GSK)

GlaxoSmithKline- one of the world's leading research-based pharmaceutical and healthcare companies - is committed to improving the quality of human life by enabling people to do more, feel better and live longer. *

	Start	2022-05-16 renamed
	Group	GSK (Group)
	Predecessor	GlaxoSmithKline plc (LSE: GSK, NYSE: GSK)
	Industry	pharmaceutical

	Region	London, Greater London
	Country	United Kingdom (GB)
	City	n. a.
		Address record changed: 2022-06-02

Basic data	Employees	n. a.
	Currency	GBP
	Annual sales	29,324,000,000 (turnover, consolidated (2022) 2022-12-31)
	Profit	15,621,000,000 (2022-12-31)
	Cash	3,723,000,000 (2022-12-31)

		* Document for »About Section«:

		Record changed: 2026-06-19

Picture EBD Group World of Partnering Opportunities 650x200px

More documents for GSK (Group)

[1] 908 Devices, Inc.. (1/7/22). "Press Release: 908 Devices Announces GSK Purchases Fifth Rebel Cell Culture Media Analyzer". Boston, MA....
[2] ELRIG (UK) Ltd.. (9/23/20). "Press Release: ELRIG UK Elects Melanie Leveridge to Lead the Organisation as Chair". York....

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com